Liposomal Vaccines: Clinical Status and Immunological Presentation for Humoral and Cellular Immunity

Annals of the New York Academy of Sciences

Volumn 754, Issue 1, 1995, Pages 143-152

  ALVING, CARL R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID A; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VACCINE;

ANTIGEN PRESENTATION; CELL ORGANELLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; VACCINATION;

INFLUENZA VIRUS;

EID: 0029023980     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb44447.x     Document Type: Article

References (56)

1. Liposomes: Parenteral administration to man
2. Liposomes as safe carriers of drugs and vaccines
3. Intramuscular absorption and regional lymphatic uptake of liposomeentrapped inulin
4. Postimmunization clearance of liposome entrapped adenovirus type 5 hexon
5. Liposomes as carriers of antigens and adjuvants
6. Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy
7. Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens
8. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A
9. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks
10. Phase 1 clinical tests of influenza MDP‐virosome vaccine (KD‐5382)
11. Novel adjuvant strategies for experimental malaria and AIDS vaccines
12. Safety evaluation of vaccine adjuvants
13. Antiviral cytotoxic T lymphocyte induction and vaccination
14. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
15. Adjuvant effects of liposomes containing lipid A: Enhancement of liposomal antigen presentation and recruitment of macrophages
16. Liposomes in immunology: the immune response against antigen‐containing liposomes
17. The role of macrophages in promoting the antibody response mediated by liposome‐associated protein antigens
18. Presentation of an MuLV‐related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer
19. The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome‐associated albumin antigen
20. Immunologic aspects of liposomes: Presentation and processing of liposomal protein and phospholipid antigens
21. Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression
22. Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation of peritoneal macrophages and B cell tumors
23. In duction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells
24. Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen
25. Macrophages as accessory cells for class I MHC‐restricted immune responses
26. H‐2 antigens incorporated into phospholipid vesicles elicit specific allogeneic cytotoxic T lymphocytes
27. A study of the inability of subcellular fractions to elicit primary anti‐H‐2 cytotoxic T lymphocytes
28. In vitro induction of primary and secondary xenoimmune responses by liposomes containing human colon tumor cell antigens
29. Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes
30. Liposome encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation
31. pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein
32. An improved method of loading pH‐sensitive liposomes with soluble proteins for class I restricted antigen presentation
33. Development of a new type of influenza subunit vaccine made by muramyldipeptide‐liposome: enhancement of humoral and cellular immune responses
34. Induction of cytolytic T cell responses by the repeatless Plasmodium falciparum circumsporozoite protein molecule incorporated into liposomes
35. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes
36. Processing of exogenous liposomeencapsulated antigens in vivo generates class I MHC‐restricted T cell responses
37. Liposome‐mediated delivery stimulates a class Irestricted cytotoxic T cell response to soluble antigen
38. A rational design of synthetic peptide vaccine with a built‐in adjuvant
39. Design of a complete synthetic peptide‐based AIDS vaccine with a built‐in adjuvant
40. Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen‐presentation pathway
41. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway
42. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus‐specific CD‐8+ cytotoxic T lymphocytes
43. Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes
44. Cellular interactions in the humoral immune response
45. Antigen presentation at the inflammatory site
46. Antigen presentation
47. The cell biology of antigen processing and presentation
48. Introduction of soluble protein into the class I pathway of antigen processing and presentation
49. A vital stain for the Golgi apparatus
50. ATP‐dependent fusion of liposomes with the Golgi apparatus of perforated cells
51. The Golgi apparatus: insights from lipid biochemistry
52. Lipid traffic in eukaryotic cells: mechanisms for intraccllular transport and organelle‐specific enrichment of lipids
53. In vitro fusion of rabbit liver Golgi membranes with liposomes
54. Identity of the 19S “prosome” particle with the large multifunctional protease complex of mammalian cells (the proteasome)
55. Antigen processing
56. Proteasomes in the pathway